In November 2016 a measles and rubella elimination strategy group was established to oversee the development of a United Kingdom-wide Measles and Rubella elimination strategy, which will outline the UK\u2019s renewed commitment to the World Health Organization targets and make recommendations for further action.<\/p>
<\/p>
Public Health England (PHE) and NHS England work closely with providers at a local level to target specific communities where uptake of the Measles Mumps and Rubella vaccine is known to be poor, as well as widening access by commissioning a range of alternative providers to complement existing general practitioner activities and community health service delivered immunisations.<\/p>
<\/p>
PHE also contributes to national standard development and setting for immunisation providers and commissioners, which includes recommendations for commissioners and providers on increasing immunisation uptake among children and young people in groups and settings where immunisation coverage is low.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberConstituency" : {"_value" : "Oxford West and Abingdon"} , "answeringMemberPrinted" : {"_value" : "Nicola Blackwood"} , "dateOfAnswer" : {"_value" : "2017-02-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-02-08T16:10:33.617Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-01-31", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "MMR Vaccine"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to reach the WHO target of at least 95 per cent of children at age two are vaccinated for MMR.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"} } , "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"} , "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"} ], "uin" : "62567"} , {"_about" : "http://data.parliament.uk/resources/713496", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/713496/answer", "answerText" : {"_value" : "
Annual uptake data is collected at national and local authority level; therefore data is available for Lancashire and England, but not Pendle constituency. The data can be found in the Cover of vaccination evaluated rapidly (COVER) programme reports, available at:<\/p>
https://www.gov.uk/government/collections/vaccine-uptake<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
}
, "answeringMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
, "answeringMemberPrinted" : {"_value" : "Nicola Blackwood"}
, "dateOfAnswer" : {"_value" : "2017-03-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-03-30T14:05:06.403Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-03-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "MMR Vaccine"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many children have received the MMR vaccination in each year since 2012 in (a) Pendle constituency, (b) Lancashire and (c) England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "tablingMemberConstituency" : {"_value" : "Pendle"}
, "tablingMemberPrinted" : [{"_value" : "Andrew Stephenson"}
], "uin" : "69035"}
, {"_about" : "http://data.parliament.uk/resources/1057038", "AnsweringBody" : [{"_value" : "Department for Digital, Culture, Media and Sport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1057038/answer", "answerText" : {"_value" : " The Government takes all attempts to deliberately disrupt and confuse the information environment very seriously. It is difficult to attribute the slight decline in uptake of the MMR vaccinations to any one source, however, we will work with our colleagues in the Department of Health and Social Care and Public Health England to assess the impact that disinformation and manipulation of social and traditional media may have on this issue.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4115", "label" : {"_value" : "Biography information for Margot James"}
}
, "answeringMemberConstituency" : {"_value" : "Stourbridge"}
, "answeringMemberPrinted" : {"_value" : "Margot James"}
, "dateOfAnswer" : {"_value" : "2019-02-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-13T16:38:08.727Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "10"}
, "answeringDeptShortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "answeringDeptSortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "date" : {"_value" : "2019-02-08", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "MMR Vaccine"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Digital, Culture, Media and Sport, whether his Department has made an assessment of the role of social and traditional media in the decline in levels of uptake of the MMR vaccination.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4425", "label" : {"_value" : "Biography information for Jo Stevens"}
}
, "tablingMemberConstituency" : {"_value" : "Cardiff Central"}
, "tablingMemberPrinted" : [{"_value" : "Jo Stevens"}
], "uin" : "218819"}
, {"_about" : "http://data.parliament.uk/resources/1110022", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1110022/answer", "answerText" : {"_value" : " Public Health England routinely monitors coverage for the national immunisation programme, including the measles, mumps and rubella (MMR) vaccine on a quarterly and annual basis.<\/p> <\/p> National coverage figures reported for the MMR first dose as measured at five years show coverage, which reached the World Health Organization recommended target level of 95% for the first-time last year, was 94.9% in England in 2017-18. Uptake of the second MMR dose by age five years in England was 87.2%. The 2017/18 data can be viewed at the following link:<\/p> <\/p> https://files.digital.nhs.uk/55/D9C4C2/child-vacc-stat-eng-2017-18-report.pdf<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-04-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-10T13:26:53.66Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-04-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "MMR Vaccine"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the child MMR vaccination rates.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"}
}
, "tablingMemberConstituency" : {"_value" : "Coventry South"}
, "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"}
], "uin" : "241384"}
, {"_about" : "http://data.parliament.uk/resources/1132104", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1132104/answer", "answerText" : {"_value" : " There has been an increase in cases of measles since the end of 2017 with close to 1,000 cases reported in 2018. However, the majority of these cases (628/966, 65%) are in individuals aged less than one year old and over 15 years i.e. those not in recently vaccinated age cohorts. Data is available at the following link:<\/p> https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2018<\/a><\/p> An increase in mumps activity was observed in England in the first quarter (Q1) of 2019 with 795 laboratory confirmed mumps infections. Almost half (352/795, 44%) of the cases in Q1 were in unvaccinated individuals. This data can be viewed at the following link:<\/p> https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804024/hpr1819_mmr2.pdf<\/a><\/p> The World Health Organization confirmed that the United Kingdom had eliminated rubella in 2015. Between 2013-18 there were only 10 laboratory confirmed cases in England. This data can be viewed at the following link:<\/p> https://www.gov.uk/government/publications/rubella-confirmed-cases/rubella-notifications-and-confirmed-cases-by-oral-fluid-testing-in-england-2013-to-2014-by-quarter<\/a><\/p> Nearly all these cases have been in individuals born abroad and were not eligible to receive rubella containing vaccine in United Kingdom.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1132104/answer/previousversion/123818", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
}
, "questionFirstAnswered" : [{"_value" : "2019-06-24T16:57:13.03Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "MMR Vaccine"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the correlation between falling rates of vaccination for measles, mumps and rubella and the increased incidence of those conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4077", "label" : {"_value" : "Biography information for Emma Reynolds"}
}
, "tablingMemberConstituency" : {"_value" : "Wolverhampton North East"}
, "tablingMemberPrinted" : [{"_value" : "Emma Reynolds"}
], "uin" : "264387"}
, {"_about" : "http://data.parliament.uk/resources/1141381", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1141381/answer", "answerText" : {"_value" : " Two Measles, Mumps and Rubella (MMR) vaccines are licensed for use in the United Kingdom: M-M-RVaxPro and Priorix. Both vaccines are on the National Health Service\u2019s routine immunisation schedule. The quality, safety and efficacy of both M-M-RVaxPro and Priorix have been evaluated before they were given a Marketing Authorisation in Europe, and the Marketing Authorisation Holder for each vaccines is legally required to submit periodic safety update reports to the regulator, which are documents intended to provide an evaluation of the risk-benefit balance of a medicinal product at defined time points after its authorisation. The sites at which the products are manufactured are also required to undergo periodic inspections to ensure that they comply with Good Manufacturing Practices. Each batch of vaccines is tested by an official medicines control laboratory (OMCL). OMCL testing is independent of and in addition to the manufacturer\u2019s testing. These procedures ensure that the MMR vaccines available in the UK are safe and efficacious and that the manufacturers/Marketing Authorisation holders are held accountable for their products.<\/p> A European Public Assessment Report (EPAR) for M-M-RVaxPro is available at the following link:<\/p>
-<\/p><\/td> | 24 months<\/p><\/td> | Five years<\/p><\/td> | Five years<\/p><\/td><\/tr> |
-<\/p><\/td> | % MMR (1st Dose)<\/p><\/td> | % MMR (1st Dose)<\/p><\/td> | % MMR (1st and 2nd Dose)<\/p><\/td><\/tr> |
2013-14<\/p><\/td> | 92.7<\/p><\/td> | 94.1<\/p><\/td> | 88.3<\/p><\/td><\/tr> |
2014-15<\/p><\/td> | 92.3<\/p><\/td> | 94.4<\/p><\/td> | 88.6<\/p><\/td><\/tr> |
2015-16<\/p><\/td> | 91.9<\/p><\/td> | 94.8<\/p><\/td> | 88.2<\/p><\/td><\/tr> |
2016-17<\/p><\/td> | 91.6<\/p><\/td> | 95.0<\/p><\/td> | 87.6<\/p><\/td><\/tr> |
2017-18<\/p><\/td> | 91.2<\/p><\/td> | 94.9<\/p><\/td> | 87.2<\/p><\/td><\/tr> |
2018-19<\/p><\/td> | 90.3<\/p><\/td> | 94.5<\/p><\/td> | 86.4<\/p><\/td><\/tr><\/tbody><\/table> Source:<\/p> |